Annovis Operating Expenses Trend from 2010 to 2022

ANVS -  USA Stock  

USD 9.15  0.17  1.89%

Annovis Bio Operating Expenses yearly trend continues to be relatively stable with very little volatility. Operating Expenses is likely to grow to about 15.7 M this year. During the period from 2010 to 2022, Annovis Bio Operating Expenses destribution of quarterly values had r-value of  0.73 from its regression line and mean deviation of  4,077,281. Annovis Bio Operating Expenses is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Operating Expenses of 14.54 Million. As of 05/24/2022, Research and Development Expense is likely to grow to about 9.1 M, while Consolidated Income is likely to drop (14.9 M).
  
Refresh
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis main balance sheet or income statement drivers, such as Operating Expenses of 15.7 M, Research and Development Expense of 9.1 M or Selling General and Administrative Expense of 4.8 M, as well as many exotic indicators such as Book Value per Share of 6.3, Current Ratio of 32.94 or Debt to Equity Ratio of 0.0367. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules. It can also supplement various Annovis Bio Technical models. Please continue to the analysis of Annovis Bio Correlation against competitors.

Annovis Bio Quarterly Operating Expenses

5.91 Million

Share

Annovis Operating Expenses Breakdown

Showing smoothed Operating Expenses of Annovis Bio with missing and latest data points interpolated. Operating expenses represents the total expenditure on [SGnA]; [RnD] and other operating expense items; it excludes [CoR].Annovis Bio's Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.
Operating Expenses10 Years Trend
Increasing
Slightly volatile
 Operating Expenses 
Share
      Timeline 

Annovis Operating Expenses Regression Statistics

Arithmetic Mean 3,453,338
Geometric Mean 1,442,557
Coefficient Of Variation 157.18
Mean Deviation 4,077,281
Median 713,937
Standard Deviation 5,428,111
Range 14,970,959
R-Value 0.73
R-Squared 0.53
Significance 0.004566
Slope 1,018,255

Annovis Operating Expenses History

20191.6 M
20206.6 M
202114.5 M
202215.7 M

About Annovis Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Annovis Bio income statement, its balance sheet, and the statement of cash flows. Annovis Bio investors use historical funamental indicators, such as Annovis Bio's Operating Expenses, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may use each financial statement separately, they are all related. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Annovis Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Annovis Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Annovis Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Operating Expenses14.5 M15.7 M
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Annovis Bio without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Pair Trading with Annovis Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will appreciate offsetting losses from the drop in the long position's value.

Annovis Bio Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Annovis Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis Bio to buy it.
The correlation of Annovis Bio is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Annovis Bio Correlation against competitors. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.